Skip to content

Insider · CIK 0001222356

MARCHETTI ROGER

Reports to the SEC for 3 companies · SAN DIEGO, CA

Transactions

30

Companies

3

Filings

5

CIK

0001222356

Forms 4 and 5

Insider transactions

30 trades
DateCompanyValue
2013-08-15CAREFUSION CorpM Exercise/Conversion—
2013-08-15CAREFUSION CorpF Tax Payment−$157K
2013-08-15CAREFUSION CorpRestricted Stock UnitsM Exercise/Conversion—
2013-08-15CAREFUSION CorpRestricted Stock UnitsM Exercise/Conversion—
2013-08-15CAREFUSION CorpRestricted Stock UnitsM Exercise/Conversion—
2013-08-15CAREFUSION CorpRestricted Stock UnitsA Award—
2013-08-15CAREFUSION CorpOptions (right to buy)A Award—
2012-08-15CAREFUSION CorpM Exercise/Conversion—
2012-08-15CAREFUSION CorpF Tax Payment−$85.1K
2012-08-15CAREFUSION CorpRestricted Stock UnitsM Exercise/Conversion—
2012-08-15CAREFUSION CorpRestricted Stock UnitsA Award—
2012-08-15CAREFUSION CorpOptions (right to buy)A Award—
2011-08-15CAREFUSION CorpRestricted Stock UnitsA Award—
2011-08-15CAREFUSION CorpOptions (right to buy)A Award—
2011-03-01AMYLIN PHARMACEUTICALS INCA Award—
2011-03-01AMYLIN PHARMACEUTICALS INCA Award—
2011-03-01AMYLIN PHARMACEUTICALS INCIncentive Stock Option (right to buy)A Award—
2011-03-01AMYLIN PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award—
2010-02-03AMYLIN PHARMACEUTICALS INCA Award+$7,345.96
2010-02-03AMYLIN PHARMACEUTICALS INCA Award—
2010-02-02AMYLIN PHARMACEUTICALS INCIncentive Stock Option (right to buy)A Award—
2010-02-02AMYLIN PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award—
2009-03-04AMYLIN PHARMACEUTICALS INCA Award—
2009-03-04AMYLIN PHARMACEUTICALS INCIncentive Stock Option (right to buy)A Award—
2009-03-04AMYLIN PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award—
2009-03-04AMYLIN PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award—
2009-02-03AMYLIN PHARMACEUTICALS INCA Award+$6,903
2008-02-01AMYLIN PHARMACEUTICALS INCA Award+$6,734
2007-01-31AMYLIN PHARMACEUTICALS INCA Award+$15K
2005-06-01GUIDANT CORPA Award—

Recent filings

5